Clinical Trial Update: A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of HS-410 in non-muscle invasive bladder cancer was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• HS-410

Snippet

Sponsor: Heat Biologics | Conditions: Bladder Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-02-17